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Background
Lactococcus lactis is one of the best studied bacteria. After
its isolation more than 100 years ago, it first received
attention as dairy bacterium because of its importance in
cheese and butter fermentations. Following the develop-
ment of genetic engineering, it quickly became the para-
digm lactic acid bacterium. Today the genomes of three
different strains of the genus L. lactis are elucidated and
prototype genome-based complete metabolic models are
developed. The development of the NIisin Controlled
gene Expression (NICE) system about 10 years ago greatly
facilitated progress in many areas of research not only in
Lactococcus itself, but also in all other lactic acid bacteria.
Results
The NICE system is a straightforward, easy to use system
(plug-and-play genetic toolbox) for strictly controlled
expression of homologous and heterologous genes. The
advantages of L. lactis as gene expression system over e.g.
E. coli are that it is food grade (including the selection
marker), does not produce endotoxins or inclusion bod-
ies, it has very low protease activity, does not sporulate
and it has only one membrane. At present, the NICE sys-
tem is quickly growing into an important tool for express-
ing and studying prokaryotic and eukaryotic membrane
proteins. Furthermore, the NICE system is growing
beyond its initial role as a research tool and is used for the
production of oral and live vaccines and for the large scale
production (3000 L) of pharmaceutical proteins such as
lysostaphin.
Conclusion
The presentation will describe the principle of the NICE
system, give an overview of current applications and an
outlook on future developments
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